Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann, P Chappuis… - Journal of medical …, 2022 - jmg.bmj.com
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …
被引用次数：18 相关文章

Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann, P Chappuis… - Journal of Medical …, 2022 - search.proquest.com
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …
[PDF] unige.ch

[PDF][PDF] Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann, P Chappuis… - …, 2022 - access.archive-ouverte.unige.ch
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …

Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann… - Journal of medical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …
[PDF] swisscascade.ch

[PDF][PDF] Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann, P Chappuis, N Buerki… - swisscascade.ch
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …

Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.

I Salikhanov, K Heinimann, P Chappuis… - Journal of medical …, 2022 - boris.unibe.ch
BACKGROUND We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …

Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.

I Salikhanov, K Heinimann, P Chappuis… - Journal of Medical …, 2021 - europepmc.org
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …

Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann… - Journal of Medical …, 2021 - digitalcollection.zhaw.ch
Background: We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …
[PDF] bmj.com

[PDF][PDF] Swiss cost-effectiveness analysis of universal screening for Lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives

I Salikhanov, K Heinimann, P Chappuis… - Journal of Medical …, 2021 - jmg.bmj.com
Background We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …

Swiss cost-effectiveness analysis of universal screening for lynch syndrome of patients with colorectal cancer followed by cascade genetic testing of relatives.

I Salikhanov, K Heinimann, P Chappuis, N Buerki… - 2021 - cabidigitallibrary.org
Background: We estimated the cost-effectiveness of universal DNA screening for Lynch
syndrome (LS) among newly diagnosed patients with colorectal cancer (CRC) followed by …